Bioliberty

Bioliberty

Private
EdinburghHealthcare & Life Scienceshttps://bioliberty.com

Last Round

Series A

Mar 19, 2026

Total Funding Raised

$3.4M

Momentum Score

25 /100

Company Overview

Bioliberty is a medical technology company that develops soft robotic wearables and a digital therapy platform to assist with patient recovery from mobility-limiting conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Vertical SaaS, Patient Engagement, Healthcare Analytics

Business Model

B2B

Customer Profile

Hardware + Subscription, Government Contracts

AI Layer

Non-AI

Keywords

soft robotic glovestroke rehabilitationrehabilitation technologyrehab techwearable roboticsgamified therapymedical devicehand rehabilitationdigital therapy platformupper limb rehabilitationassistive technologymedtechneurological rehabilitationpatient progress tracking

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bioliberty Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Bioliberty Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AMar 19, 2026
GrantDec 4, 2023
SeedApr 4, 2023
GrantDec 8, 2022

Key People

Founding team and executive leadership

Conan Bradley

Co-Founder And Chief Commercial Officer

Founding Team

Ross O'Hanlon

Co-Founder CTO

Founding Team

Shea Quinn

Co-Founder Chief Operating Officer

Founding Team

Barry Hextall

Chief Financial Officer

Executive Team

Bioliberty Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 19, 2026

    $8.27M round completed.

  • Oct 1, 2025

    Core technologies Lifehub and Lifeglov are FDA-registered.

Bioliberty Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Bioliberty Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Bioliberty's valuation, stock price, and market status.

Firmographic Details

HeadquartersEdinburgh
Employee Range28
Year Founded2020
Last FundingMar 19, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.